Have you been diagnosed with NASH/MASH?
Participating in a clinical research study might be an option for you.
See If You Qualify
Thank you for your interest in our clinical research study. Please provide your contact details and basic information below so a member of our research team can reach out to discuss the study with you.
- No cost to check eligibility
- No obligation to participate
- A coordinator confirms eligibility by phone
- You can withdraw at any time
This pre-screening does not guarantee enrollment.
Common Questions
What is a clinical trial?
A clinical trial is a carefully designed research study involving human volunteers to investigate the safety and effectiveness of a new drug or treatment. Clinical trials are essential for evaluating the benefits and risks of medical interventions, ultimately informing healthcare decisions and regulatory approvals.
Are clinical trials safe?
Clinical trials are designed with a strong emphasis on participant safety. Multiple safeguards are in place, including careful study design, oversight by institutional review boards, and routine monitoring of study data by independent experts. Researchers must inform participants of any risks, benefits, and side effects they discover.
What are my obligations as a participant?
Responsibilities vary by study but may include diagnostic tests, treatments, procedures, doctor visits, and lifestyle changes. Our team will walk you through everything before you commit to anything.
Can I drop out of a study?
Yes. You can withdraw at any time without any penalties or consequences. Voluntary participation is a fundamental principle of clinical research — you are never obligated to continue.
How do I know if I’m eligible?
Fill out the short form here and a member of our team will review your information and reach out to discuss the study with you. If you’re not eligible for this trial, you may still qualify for other studies we’re running.
Overview
Researchers are studying a new medication called pegozafermin to see if it can help treat Metabolic Dysfunction-Associated Steatohepatitis (MASH), previously called Nonalcoholic Steatohepatitis (NASH), a form of fatty liver disease that can lead to liver damage over time.
The goal of the study is to learn whether pegozafermin can improve liver health and reduce liver scarring over a treatment period of about 52 weeks (one year).
Researchers will compare liver biopsy results from the beginning of the study and after one year to see whether the treatment helps improve the condition of the liver.
Join a (MASH/NASH) Fatty Liver Research Study
Your participation may help researchers learn more about potential new treatments for MASH.
About the Study
We are currently seeking patients with fatty liver for research studies focused on advancing treatments for Metabolic Dysfunction-Associated Steatohepatitis (MASH), also known as Nonalcoholic Steatohepatitis (NASH).
A Pegozafermin Study
This study is testing a new type of treatment that uses gene silencing to target MASH. This research is focused on people who have specific genetic risk factors for the disease.
By participating, you could help advance the development of new and effective treatment options for MASH/NASH.
Non-Alcoholic Steatohepatitis (NASH)
Liver Fibrosis
Benefits
Study-Related Care
Study related medication and care provided at no cost
No Insurance Needed
Health insurance is not required.
Compensation
Qualified participants may earn up to $1300 during the first year and up to $2600 throughout the duration of the study (3 years).
Who Can Join
To qualify, you must:
Be 18-80 years old
Be diagnosed with non-alcoholic steatohepatitis (NASH), now also called metabolic dysfunction-associated steatohepatitis (MASH)
Have a BMI of 25 or higher
Not be diagnosed with other liver disorders other than NASH
*Other conditions may apply
Check Your BMI
Enter your details to see if you meet the BMI requirement for this study.
What to Expect
* Eligible participants may receive compensation for completing all required study-related activities.
Liver Biopsy
Undergo a liver biopsy so researchers can study liver health
MRI
Complete up to 3 MRI scans to help evaluate the liver
Study Visits
Attend scheduled study visits and phone check-ins with the research team
Participating Locations
Know Someone Who Might Qualify?
Share this study with a friend or family member who may benefit.